Powered by: Motilal Oswal
18/04/2023 10:30:53 AM | Source: Accord Fintech
Krsnaa Diagnostics rises on receiving Tender from Mira-Bhayandar Municipal Corporation, Thane
News By Tags | #6871 #642 #572
Krsnaa Diagnostics rises on receiving Tender from Mira-Bhayandar Municipal Corporation, Thane

Krsnaa Diagnostics is currently trading at Rs. 498.30, up by 4.30 points or 0.87% from its previous closing of Rs. 494.00 on the BSE.

The scrip opened at Rs. 498.25 and has touched a high and low of Rs. 508.85 and Rs. 498.05 respectively. So far 608 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 655.00 on 28-Apr-2022 and a 52 week low of Rs. 354.00 on 28-Feb-2023.

Last one week high and low of the scrip stood at Rs. 515.45 and Rs. 486.75 respectively. The current market cap of the company is Rs. 1571.61 crore.

The promoters holding in the company stood at 27.80%, while Institutions and Non-Institutions held 23.55% and 48.66% respectively.

Krsnaa Diagnostics has received Tender from Mira-Bhayandar Municipal Corporation, Thane, Maharashtra.  As per the Tender awarded, the company will set up a MRI, CT Scan, Sonography- Ultrasound, X-Ray Center and Pathology Lab to serve the patients falling under the jurisdiction of Mira-Bhayandar Municipal Corporation on Public Private Partnership (PPP) basis.  The nature project will be design, finance, construction, marketing and operation of the Diagnostics Center at the above referred location.

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here